The global single-cell omics market is expected to grow from $555.3 million in 2017 to nearly $1.6 billion in 2022, at a compound annual growth rate (CAGR) of 23.5% from 2017 to 2022.
Report Scope:
The scope of this report includes single cell analysis technologies, applications, industries, major funding initiatives, patents and companies. The market sizes for single cell products are given for the years 2015, 2016, 2017 (estimated) and 2022 (forecasted).
This report reviews the single cell workflow steps and technologies and provides background on why single cell analysis is important. It then discusses some of the top research initiatives that are contributing to single cell applications. Market driving forces are also discussed.
The structure of several important industry subsectors is reviewed, as well as major industry acquisitions and strategic alliances from Jan. 2016 to Sept. 2017. Industry subsectors analyzed include target enrichment, droplet digital PCR, single cell DNA polymerase, DNA amplification, next generation sequencing (NGS) instruments, single cell proteomics, circulating tumor cell (CTC) capture and detection, liquid biopsy, preimplantation testing and immune sequencing.
The market for single cell analysis technologies is analyzed in depth. The market is analyzed by end user, application field, product type, omics method used, cell type, clinical indication and geography.
Specific geographic markets are discussed, including North America, Europe, Asia-Pacific and the rest of the world.
Market data covers the years 2015, 2016, 2017 (estimated) and 2022 (forecast).
More than 90 companies in the single cell analysis industry are profiled in this report.
BCC Research provides a summary of the main industry acquisitions and strategic alliances from Jan. 2016 through Sept. 2017, including key alliance trends.
Report Includes:
- 71 tables
- An overview of the global markets and emerging technologies for single-cell genomics and proteomics
- Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Cell isolation technologies, including flow cytometry, laser capture microscopy, and micromanipulation
- Sample preparation technologies, including microfluidics, whole genome amplification/pre-amplification
- Analyses of next-generation sequencing, qPCR/PCR, microarrays, mass spectrometry, and microfluidics
- End-use industry coverage, including research, drug discovery and development, diagnostics, and applied
- Evaluation of the market's dynamics, including growth drivers, restraints, and opportunities
- Profiles of major players in the industry including 1 Cellbio, 10x Genomics Inc., Angle PLC, Aviva Biosciences, Boreal Genomics, Dolomite Bio and Hifibio
Summary
Single-cell omics analysis technologies are emerging as a disruptive force in the life science research, pharmaceutical and diagnostics industries. Single cell analysis is critical for analyzing complex, heterogeneous biological systems that occur at many levels of life sciences from stem cell biology to cancer to forensics.
In cancer, for example, a tumor may shed cells into the bloodstream that give clues about the aggressiveness of that tumor or how it is responding to a particular drug therapy. It is important to analyze these individual cells, called circulating tumor cells, to aid in monitoring the disease or to guide therapy strategies. The emerging field of liquid biopsy addresses this medical need.
Single-cell omics are also important to fundamental biological research, for example, to identify cancer mutation drivers or factors that influence stem cell potency. The trend toward biological drugs, stem cell therapies and new cancer treatments is also beneficial to the single cell analysis markets due to its importance in these fields.
Report Scope:
The scope of this report includes single cell analysis technologies, applications, industries, major funding initiatives, patents and companies. The market sizes for single cell products are given for the years 2015, 2016, 2017 (estimated) and 2022 (forecasted).
This report reviews the single cell workflow steps and technologies and provides background on why single cell analysis is important. It then discusses some of the top research initiatives that are contributing to single cell applications. Market driving forces are also discussed.
The structure of several important industry subsectors is reviewed, as well as major industry acquisitions and strategic alliances from Jan. 2016 to Sept. 2017. Industry subsectors analyzed include target enrichment, droplet digital PCR, single cell DNA polymerase, DNA amplification, next generation sequencing (NGS) instruments, single cell proteomics, circulating tumor cell (CTC) capture and detection, liquid biopsy, preimplantation testing and immune sequencing.
The market for single cell analysis technologies is analyzed in depth. The market is analyzed by end user, application field, product type, omics method used, cell type, clinical indication and geography.
Specific geographic markets are discussed, including North America, Europe, Asia-Pacific and the rest of the world.
Market data covers the years 2015, 2016, 2017 (estimated) and 2022 (forecast).
More than 90 companies in the single cell analysis industry are profiled in this report.
BCC Research provides a summary of the main industry acquisitions and strategic alliances from Jan. 2016 through Sept. 2017, including key alliance trends.
Reasons for Doing This Study:
The life science industry is moving towards digitization with the advent of newer technologies including advanced genetic sequencing and microfluidics systems. As many biological systems contain heterogeneous populations of cells, heretofore many analysis methods measured mixtures of different cell types.
Single cell analysis is a disruptive technology that enables analysis of single cells out of a complex mixture of cells. This type of analysis is key to understanding complex systems in fields as diverse as neurology, stem cell biology and cancer.
At the same time, advances in genome editing, high-throughput systems and microfluidics technologies have enabled the rapid, parallel analysis of smaller samples that are common with single cells. Based on this, single cell analysis markets are rapidly emerging and the need for industry and market characterization is great.
Also, the single cell field is growing beyond basic research into applied fields and molecular diagnostics applications.
The outstanding growth potential for single cell analysis products makes it particularly timely for doing this updated report.
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology
Information Sources
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Overview
Introduction
Report Scope
Workflow
Technology Challenges
Markets
Growth Driving Forces
Key Trends
Industry
Chapter 4 Technology Background
What Makes Single-cell Analysis Unique?
Single-cell Omics
Single-cell Analysis Workflow
Cell Isolation Technologies
Sample Preparation Technologies
Analysis Technologies
DNA Encoded Libraries in Single Cell Analysis
Genome-edited Single Cell Technologies
High-throughput Single-cell Technologies
Single-cell Multi-omics Technology
Single-cell RNA-Seq Technologies
Single-cell Technology Challenges
Chapter 5 Single-cell Initiatives and Cores
4D Nucleome Project
Allen Human Brain Atlases
Allen Institute of Cell Science
Brain Initiative
Centre of Single-cell Biology
Follow That Cell Challenge
Human Cell Atlas Initiative
Microbial Dark Matter Project
Next-Generation Single-cell Analysis Program
Single-cell Analysis Program
Single-cell Analysis Program-Transcriptome Project
Single-cell Proteomics and Lipidomics Project
Single-cell Surveyor Society
Cambridge Single-cell Analysis Core Facility
Harvard Medical School Single-cell Core
Mayo Medical Genome Facility
National Center for Single-cell Biology
Single-cell Analysis Core
UC San Francisco Single-cell Analysis Center
Chapter 6 Single-cell Applications
Introduction
Basic Cell Biology
Immunology
Microbiology
Neurology
Oncology
Stem Cell Biology
Liquid Biopsy
Preimplantation Genetic Diagnosis and Screening
Human Identification
Agriculture
Chapter 7 Single-cell Industry
Introduction
Target Enrichment Industry
Droplet Digital PCR Industry
Single-cell DNA Polymerase Industry
DNA Amplification Industry
NGS Instrument Industry
Single-cell Proteomics Industry
CTC Capture and Detection Industry
Liquid Biopsy Industry
Preimplantation Testing Industry
Immune Sequencing Industry
Chapter 8 Acquisitions and Strategic Alliances
Acquisitions
Strategic Alliances
Chapter 9 Single-cell Omics Markets
Growth Driving Forces
Single-cell Omics Market
Single-cell omics Diagnostics Markets
Breast Cancer
Colorectal Cancer
Ovarian Cancer
Lung Cancer
Multiple Myeloma
Prostate Cancer
Research Market
Drug Discovery and Development Market
Applied Market
Single-cell Omics Geographical Market
Chapter 10 Patent Review
Chapter 11 Company Profiles
1 CELLBIO
10X GENOMICS INC.
ACCELERATE DIAGNOSTICS INC.
AGILENT TECHNOLOGIES INC.
AMBRY GENETICS
ANGLE PLC
APOCELL INC.
ASURAGEN INC.
ATRECA INC.
AVIVA BIOSCIENCES
BECTON, DICKINSON AND CO.
BERRY GENOMICS CO. LTD.
BGI SHENZHEN
BIOARRAY S.L.
BIOCEPT INC.
BIOFLUIDICA INC.
BIO-RAD LABORATORIES INC.
BIO-TECHNE LTD.
BOREAL GENOMICS
CELL MICROSYSTEMS INC.
CELSEE DIAGNOSTICS
CELLULAR RESEARCH INC.
CHRONIX BIOMEDICAL
CIRCULOMICS INC.
COOPER SURGICAL INC.
CYNVENIO BIOSYSTEMS INC.
CYTENA GMBH
CYTOLUMINA TECHNOLOGIES CORP. INC.
CYTOTRACK APS
DANAHER CORP.
DIAGNOLOGIX LLC
DNA ELECTRONICS LTD.
DOLOMITE BIO
ENGINE BIOSCIENCES PTE. LTD.
EPIC SCIENCES
EXOSOME DIAGNOSTICS INC.
FETOLUMINA TECHNOLOGIES CORP.
FLOWJO LLC
FLUIDIGM CORP
FLUXION BIOSCIENCES INC.
GE HEALTHCARE
GIGAGEN INC.
GILUPI GMBH
GOOD START GENETICS INC.
HIFIBIO
HTG MOLECULAR DIAGNOSTICS INC.
ILLUMINA INC.
INCELLDX INC.
ISOPLEXIS CORP.
KELLBENX INC.
LABORATORY CORP. OF AMERICA INC.
LGC BIOSEARCH TECHNOLOGIES
MENARINI SILICON BIOSYSTEMS
MERCK KGAA
MISSION BIO INC.
MUSE BIOTECHNOLOGY INC.
NAMOCELL INC.
NANOCELLECT BIOMEDICAL INC.
NANOSTRING TECHNOLOGIES INC.
NATERA INC.
NEW ONCOLOGY GMBH
NODALITY INC.
NUGEN TECHNOLOGIES INC.
OXFORD NANOPORE TECHNOLOGIES LTD.
PACIFIC BIOSCIENCES OF CALIFORNIA INC.
PERKINELMER INC.
QIAGEN NV
RARECELLS SAS
RARECYTE INC.
RAVATA SOLUTIONS
REPRODUCTIVE HEALTH SCIENCE PTY LTD.
RESOLUTION BIOSCIENCE INC.
ROCHE HOLDING AG
ROYAL PHILIPS
SCREENCELL
SENGENICS INTERNATIONAL PTE LTD.
SINGULOMICS CORP.
SOMAGENICS INC.
SPHERE FLUIDICS LTD.
STRATEC BIOMEDICAL AG
SWIFT BIOSCIENCES INC.
SYGNIS AG
SYSMEX CORP.
TAKARA BIO INC.
THERMO FISHER SCIENTIFIC INC.
THORNE DIAGNOSTICS INC.
TROVAGENE INC.
TUMORGEN MDX LLC
VITATEX INC.
YIKON GENOMICS CO. LTD.
Trends Market Research © Copyright 2020. All Rights Reserved.